SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPorvair Regulatory News (PRV)

Share Price Information for Porvair (PRV)

Share Price is delayed by 15 minutes
Get Live Data
830.00    14.00 (1.72%)
Bid:
824.00
Ask:
828.00
Spread: 4.00 (0.485%)
Market Cap: £382.60m
PRV Live PriceLast checked at - London Stock Exchange

Intraday Porvair Share Chart

Acquisition and Licensing agreement

26 Sep 2013 07:00

RNS Number : 9175O
Porvair PLC
26 September 2013
 



FOR IMMEDIATE RELEASE 26 September 2013

 

 

 

Licensing agreement with Thermo Fisher Scientific

 and

Acquisition of Thomas Cain Inc

Porvair plc ("Porvair"), the specialist filtration and environmental technology group today, today announces two agreements to advance its interests in the life science and environmental laboratory markets.

A technology licensing agreement has been struck with Thermo Electron Manufacturing Ltd, a division of Thermo Fisher Scientific ("Thermo"), a global leader in scientific and laboratory supplies. Under this agreement, Porvair and Thermo will commercialise an exclusive range of life science sample preparation filters. Porvair has licensed its filter technology and will manufacture the products. Thermo will undertake sales and marketing of the filters worldwide.

 

In an unrelated agreement, Porvair has acquired the business and assets of Thomas Cain Inc, a manufacturer of environmental laboratory equipment and consumables. This small acquisition will add a complementary range of block digestion instruments and consumables to Seal's water quality analysis products. The business will be integrated into Seal Analytical's operation in Wisconsin, USA.

 

Ben Stocks, Group Chief Executive, commented:

"As part of Porvair's focus on new product development, we have been working for several years with Thermo to develop a range of laboratory sample preparation products, which we are excited to see move into the commercial phase. Porvair has received a technology transfer fee and, in addition, will generate manufacturing margins and royalties on future revenues.

 

"I am pleased to welcome the staff of Thomas Cain into the Porvair Group. Their high quality product range is highly complementary to that offered by Seal Analytical and will fit well with sales and marketing programmes already underway."

 

 

For further information, please contact:

 

Porvair plc

01553 765 500

Ben Stocks, Chief Executive

Chris Tyler, Group Finance Director

Buchanan

0207 466 5000

Charles Ryland / Helen Greenwood / Clare Akhurst

 

Notes to Editors

Porvair is a group of specialist filtration and environmental technology businesses. Its businesses design and manufacture a range of bespoke consumable filtration products that are used in a range of niche filtration markets. Its principal markets are aviation, energy and industrial process, environmental laboratories and non-ferrous metals.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBUGDCGUDBGXU
Date   Source Headline
7th Mar 20169:01 amRNSHolding(s) in Company
7th Mar 20169:00 amRNSHolding(s) in Company
1st Feb 201611:38 amRNSDirector/PDMR Shareholding
25th Jan 20167:00 amRNSFull Year Results
7th Dec 20157:00 amRNSPre-close trading update and acquisition
17th Sep 20154:15 pmRNSDirector/PDMR Shareholding
15th Sep 20157:00 amRNSTrading Update
12th Aug 20151:15 pmRNSHolding(s) in Company
12th Aug 20151:11 pmRNSHolding(s) in Company
10th Jul 201512:45 pmRNSDirector/PDMR Shareholding
29th Jun 20157:00 amRNSInterim Results
23rd Jun 20155:00 pmRNSHolding(s) in Company
2nd Jun 20157:00 amRNSTrading Update
29th May 20155:31 pmRNSTotal Voting Rights
30th Apr 20157:02 amRNSDirector declaration
14th Apr 20152:55 pmRNSAGM resolutions
14th Apr 20157:00 amRNSAGM Statement and Trading Update
24th Mar 20152:25 pmRNSPosting of Accounts
11th Mar 20157:00 amRNSHolding(s) in Company
5th Feb 20157:00 amRNSHolding(s) in Company
30th Jan 20154:03 pmRNSEx-Dividend Date
27th Jan 201512:11 pmRNSDirectors' Shareholdings and Issue of Equity
26th Jan 201512:30 pmRNSDirector Declaration
26th Jan 20157:00 amRNSSignificant Contract Wins
26th Jan 20157:00 amRNSFull Year Results
4th Dec 20147:00 amRNSSignificant Contract Win
1st Dec 20147:00 amRNSPre-close trading update
5th Nov 20147:00 amRNSDirector/PDMR Shareholding
16th Sep 20147:00 amRNSInterim Management Statement
23rd Jun 20147:00 amRNSInterim Results
5th Jun 20148:50 amRNSTotal Voting Rights
3rd Jun 20147:00 amRNSTrading Update
23rd Apr 201411:39 amRNSDirector Declaration
8th Apr 20144:20 pmRNSAGM resolutions
8th Apr 20147:00 amRNSAGM Statement and IMS
25th Feb 20147:00 amRNSAppointment of Non-Executive Director
3rd Feb 201410:08 amRNSDirector/PDMR Shareholding
27th Jan 20147:00 amRNSPreliminary Results
16th Jan 20144:07 pmRNSBlocklisting Application
4th Dec 20137:00 amRNSPre-close trading update
29th Nov 20134:02 pmRNSTotal Voting Rights
26th Sep 20137:00 amRNSAcquisition and Licensing agreement
25th Sep 20134:10 pmRNSDirector/PDMR Shareholding
17th Sep 20137:00 amRNSInterim Management Statement
7th Aug 20134:32 pmRNSHolding(s) in Company
6th Aug 20137:00 amRNSContract extension
15th Jul 201311:17 amRNSHolding(s) in Company
9th Jul 20135:13 pmRNSHolding(s) in Company
28th Jun 201312:25 pmRNSHolding(s) in Company
28th Jun 201312:19 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.